Beta blockers: Evidence versus wishful thinking

American Journal of Cardiology

Volumn 83, Issue 5 B, 1999, Pages 64-67

  Andresen, Dietrich ^a   Ehlers, Hans Christoph ^a   Wiedemann, Michael ^a   Brüggemann, Thomas ^b  

^a VIVANTES KLINIKUM AM URBAN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CONFERENCE PAPER; DRUG EFFECT; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0033545685     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00038-7     Document Type: Conference Paper

References (29)

1. Patel J., Lee W., Fusilli L., Regan T.J. Antiarrhythmic efficacy of beta-adrenergic blockade during acute ischemia in the myocardium with scar. (Abstr.) Am J Med Sci. 307:1994;259-263.
2. Aronow W.S., Ahn C., Mercando A.D., Epstein S., Kronzon I. Decrease in mortality by propranolol in patients with heart disease and complex ventricular arrhythmias is more an anti-ischemic than an antiarrhythmic effect. (Abstr.) Am J Cardiol. 74:1994;613-615.
3. Waagstein F., Bristow M.R., Swedberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 342:1993;1441-1446.
4. A randomized trial of beta blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1994;1765-1773.
5. Luketich J., Friehling T.D., O'Connor K.M., Kowey P.R. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models. Am Heart J. 118:1989;265-271.
6. De Ferrari G.M., Salvati P., Grossoni M., Ukmar G., Vaga L., Patrono C., Schwartz P.J. Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed MI. J Am Coll Cardiol. 21:1993;283-290.
7. Greene H.L. Sudden arrhythmic cardiac death-mechanisms, resuscitation and classification the Seattle perspective . Am J Cardiol. 65:(suppl):1990;4B-12B.
8. The Beta blocker Heart Attack Trial. JAMA. 246:1981;2073-2074.
9. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med. 304:1981;801-807.
10. Hjalmarson A., Elmfeldt D., Herlitz J., Holmberg S., Malek I., Nyberg G., Ryden L., Swedberg K., Vedin A., Waagstein F., Waldenstrom A., Waldenstrom J., Wedel H., Wilhelmsen L., Wilhelmsson C. Effect on mortality of metoprolol in acute MI a double-blind randomied trial . Lancet. 2:1981;823-827.
11. Gottlieb S.S., McCarter R.J., Vogel R.A. Effect of beta blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 89:1998;630-638.
12. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 1988;260:2988-2093.
13. ACC/AHA Guidelines for the management of patients with acute MI. J Am Coll Cardiol. 28:1996;1328-1428.
14. Soumerai S.B., McLaughlin T.J., Spiegelman D., Hertzmark E., Thibault G., Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute MI. JAMA. 277:1997;115-121.
15. Julian D.G., Camm A.J., Frangin G., Janse M.J., Munoz A., Schwartz P.J., Simon P. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent MI EMIAT . Lancet. 349:1997;667-674.
16. Cairns J.A., Connolly S.J., Roberts R. Randomised trial of outcome after MI on patients with frequent or repetitive ventricular premature depolarisations. Lancet. 349:1997;675-683.
17. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 335:1996;1933-1940.
18. Cobb L.A., Werner J.A., Trobaugh G.B. Sudden cardiac death: II. Outcome of resuscitation, management, and future directions. Mod Concepts Cardiovasc Dis. 49:1980;37-42.
19. Myerburg R.J., Kessler K.M., Estes D., Conde C.A., Luceri R.M., Zaman L., Kozlovskis P.L., Castellanos A. A long-term survival after prehospital cardiac arrest analyses of outcome during an 8 year study . (Abstr.) Circulation. 70:1984;538-546.
20. Wiesfeld A.C., Crijns H.J., Van Dijk R.B., Schoots C.J., Elema J.D., Tuininga Y.S., Lie K.I. Potential role for endomyocardial biopsy in the clinical characterization of patients with idiopathic ventricular fibrillation. Arrhythmogenic right ventricular dysplasia, an undervalued cause. Am Heart J. 127:1994;1421-1424.
21. Codini M.A., Sommerfeldt L., Eybel C.E., Messer J.V. Clinical significance and characteristics of exercise-induced ventricular tachycardia. Cath Cardiovasc Diag. 7:1981;227-234.
22. Olshansky B., Martins J.B. Usefullness of isoproteronol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade. Am J Cardiol. 59:1987;573-577.
23. Duff H.J., Mitchell L.B., Wyse G. Antiarrhythmic efficacy of propranolol comparison of low and high serum concentrations . J Am Coll Cardiol. 8:1986;959-965.
24. Hallstrom A.P., Cobb L.A., Yu B.H., Weaver W.D., Fahrenbruch C.E. An antiarrhythtmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol. 68:1991;1025-1031.
25. Szabo B.M., Crijns H.J., Wiesfeld A.C., van Veldhuisen D.J., Hillege H.L., Lie K.I. Predictors of mortality in patient with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function importance of beta-blockade . Am Heart J. 130:1995;281-286.
26. Steinbeck G., Andresen D., Bach P., Habart R., Oeff H., Hoffmann E., von Leifner E.R. A comparison of electrophysiologic guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrythmias. N Engl J Med. 327:1992;987-992.
27. Levine J.H., Mellits E.D., Baumgardner R.A., Veltri E.P., Mower M., Grunwald L., Guarnieri T., Aarons D., Griffith L.S. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 84:1991;558-566.
28. Seidl K., Hauer B., Schwick N.G., Zahn R., Senges J. Comparison of Metoprolol and Sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardioverter/defibrillator. Am J Cardiol. 82:1998;744-748.
29. Exner D., Epstein A., Reiter M.J., Yao A., Ledingham R., Reiffel J.A., Brodcay Y., Akiyama T., Schron E., Follmann D., Anderson J. Beta blocker use and mortality in the antiarrhythmics versus implantable defibrillators (AVID) cohort. (Abstr.) Circulation. 48:(suppl):1998;I-494.